While mergers, acquisitions, and divestitures (M, A & D) offer multiple advantages like achieving economies of scale, the transactions that occur around these deals are extremely complex. Based on our experience, typically 1% of the revenue is at risk.

Genpact Regulatory Affairs, a leader in life sciences Global Regulatory Services, has deep experience helping clients prepare for Day One readiness. We enable a smooth transition that cuts across Regulatory, Supply Chain, and Quality to ensure continuity of service, while minimizing supply disruption and maintaining compliance.

Join our Genpact Regulatory Affairs experts as they share a unique, industry-leading perspective on how to manage M, A & D challenges by bringing the Regulatory, Quality, and Supply functions together.

In this presentation, you’ll get insights on:

• Maintaining global compliance during a large-scale transformation
• Accelerating your integration/divestiture/join venture timelines via methodologies, accelerators and cloud-based solutions
• Minimizing disruption in your supply chain